Woodstock Corp’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Woodstock Corp’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-16,215	Closed	-$75K	–	205
2020 Q3	$75K	Hold	16,215	–	–	0.01%	152
2020 Q2	$46K	Hold	16,215	–	–	0.01%	154
2020 Q1	$40K	Hold	16,215	–	–	0.01%	149
2019 Q4	$83K	Buy	+16,215	New	+$89.9K	0.01%	148
2019 Q2	–	Sell	-4,375	Closed	-$47K	–	161
2019 Q1	$47K	Hold	4,375	–	–	0.01%	158
2018 Q4	$35K	Hold	4,375	–	–	0.01%	157
2018 Q3	$85K	Hold	4,375	–	–	0.01%	157
2018 Q2	$79K	Hold	4,375	–	–	0.01%	158
2018 Q1	$47K	Hold	4,375	–	–	0.01%	161
2017 Q4	$184K	Hold	4,375	–	–	0.03%	152
2017 Q3	$241K	Hold	4,375	–	–	0.05%	143
2017 Q2	$812K	Hold	4,375	–	–	0.16%	96
2017 Q1	$523K	Buy	4,375 +1,552	+55%	+$163K	0.11%	113
2016 Q4	$281K	Buy	2,823 +455	+19%	+$47.9K	0.06%	137
2016 Q3	$265K	Hold	2,368	–	–	0.05%	141
2016 Q2	$243K	Buy	+2,368	New	+$237K	0.05%	142

Other funds holding SIOX

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCA

Sassicaia Capital Advisers Jericho, New York $88.8M AUM 146.47% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Woodstock Corp's SIOX Position: Q4 2020 in Review

Woodstock Corp sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q4 2020, closing a stake of 16,215 shares — an estimated $75K sold.

Woodstock Corp first reported a position in SIOX in Q2 2016 and held it in 16 quarters. The position peaked at $812K in Q2 2017. 62 funds tracked by Wall St. Rank hold SIOX as of Q4 2020.

Woodstock Corp reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Woodstock Corp sold 16,215 Sio Gene Therapies Inc. Common Stock shares in Q4 2020, an estimated $75K.
Woodstock Corp first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2016 and held it in 16 quarters.
Woodstock Corp's Sio Gene Therapies Inc. Common Stock position peaked at $812K in Q2 2017.
62 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2020.

Based on Woodstock Corp's 13F filing for Q4 2020, filed 6 Jan 2021.